Articles On Alchemia (ASX:ACL)

In what can only be described as a remarkable turnaround, the Aussie sharemarket is closing in on breakeven for 2022, with the S&P/ASX 200 (ASX: XJO) gaining another 0.7% on Wednesday. A positive lead from the US and signs of a ceasefir...

The federal budget has, understandably, been the talk of the town today, with many market watchers questioning which shares will be budget winners and which might be less fortunate. And while ASX stocks in the retail, fuel, and automotive...

Highlights Stock exchange rules determine the ex-dividend date once the corporation sets the record date. A record date is a date by which an investor must be listed as a shareholder on the company's books. An investor will get the di...

The Australian Clinical Labs Ltd (ASX: ACL) share price dropped with the market on Thursday despite the release of a strong half year update from the pathology company. The company’s shares ended the day 3.5% lower at $4.85. Australian Cli...

Australian Clinical Labs (ASX: ACL) has been collecting both swabs and earnings as a wave of COVID-19 testing propped up revenue by 61.2 per cent in the December half, reaching $538 million and thus surpassing its entire revenue for FY20....

Key points The benchmark index has started the year well after a choppy period these past few months The team at RBC Capital Markets reckon these three ASX shares are poised to deliver upside in 2022 Analysts at the firm recently upgraded...

There are a few S&P/ASX 200 Index (ASX: XJO) shares that are making a lot of revenue and profit from the high level of COVID-19 testing. A few key providers are providing millions of tests, such as Sonic Healthcare Ltd (ASX: SHL) and H...

Returns in the ASX healthcare basket were fairly robust throughout 2021. Sector earnings saw a return to pre-COVID levels as patient and service volumes began to normalise as well. The S&P/ASX 200 Health Care Index (ASX: XHJ) has clim...

ASX investors evidently shrugged off omicron fears in December, with the last month of the 2021 being the second best of the year. Ultimately, the market finished 2021 13% higher than it started. Patience pays off, unless you got in at the...

The Australian Clinical Labs Ltd (ASX: ACL) share price is tumbling today, but it’s had a whopping run lately. At the time of writing, the Australian Clinical Labs share price is $5.87. That’s 1.51% lower than its previous close but 38% hi...

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think these...

Wall Street rallies as sentiment lifts US and European stock markets finally rose overnight after three days of losses. The global rebound followed more developments on the omicron front, as British PM Boris Johnson ruled out any lockdown b...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 0.75% to 7,346.6 points. Four ASX shares that are climbing more than most today are listed bel...

The Australian Clinical Labs Ltd (ASX: ACL) share price is up more than 5% today to $5.26 after the business upgraded first-half guidance expectations. The company operates 86 laboratories across Australia, providing pathology services incl...

The arrival of omicron in Australia has led to COVID test volumes spiking again and Australian Clinical Labs (ASX:ACL) is one of the companies benefiting. This morning the company upgraded its guidance for the first half of FY22 for the sec...

21 Dec 2021 - A snapshot of the stocks on the move featuring AMP (ASX:AMP), Magellan Financial (ASX:MFG), and Australian Clinical Labs (ASX:ACL).

21 Dec 2021 - Australian Clinical Labs (ASX:ACL) has upgraded its earnings and revenue forecast for the first half of FY22, underpinned by strong demand for Covid-19 testing.

The Australian Clinical Labs Ltd (ASX: ACL) share price has hit a record high on Tuesday morning. At the time of writing, the pathology services provider’s shares are up 10% to $5.47. Why is the Australian Clinical Labs share price chargin...

Wall Street falls amid Omicron uncertainty The US stock markets fell for the third consecutive day, as the S&P 500 had its biggest three day drop since September. All three major benchmarks fell – the S&P 500 by 1.14%, the Dow Jones...

Australian Clinical Labs (ACL) acquires Medlab Pathology, who own laboratories and collection centres across New South Wales (NSW) and Queensland (QLD) The $70 million acquisition allows the deliverance of a doubling of market share to 20....

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) looks set to start the week with a decline. At the time of writing, the benchmark index is down 0.3% to 7,280.8 points. Four ASX shares that have not let that hold them back are list...

The ASX 200 Health Index (XHJ) is trading higher by 0.92% at the time of writing, compared to the broader index which is down by 0.22%. Cannabis-based medtech company, Emyria Limited (ASX:EMD), has signed an agreement with Seattle-based Cyd...

If you’re interested in adding some small caps to your portfolio, then you may want to check out the ones listed below. These small cap shares are rated highly by analysts and have been given buy ratings recently. Here’s what you need to k...

The PolyNovo Ltd (ASX: PNV) share price has been under pressure in recent weeks. Since the beginning of November, the burns treatment specialist has fallen nearly 24% in value. Meanwhile, the overall healthcare sector has gained 1.4% durin...

The ASX 200 Health Index (XHJ) is up by 1.5% at the time of writing, compared to the broader index which is up by 0.40%. Mesoblast (ASX:MSB) jumped 10% after reporting data from its Phase 3 trial of rexlemestrocel-L in chronic heart failure...

Australian Clinical Labs (ASX: ACL) is set to nearly double its number of collection centres in NSW while solidifying its presence in QLD through the $70 million acquisition of Medlab Pathology. After recently lifting its December half rev...

The healthcare sector is home to a number of companies with the potential to grow strongly in the future. Two that investors might want to get better acquainted with are listed below. Here’s why they are highly rated: Australian Clinical L...

Whether the market is up or down, there is one type of ASX stock that investors love — businesses that upgrade their expected results. If a company finds that it’s doing better than previously thought, or it’s consistently hitting the high...

The healthcare sector is having a tough week and has fallen heavily. For example, the S&P/ASX 200 Health Care index is down 7.5% since this time last week. While this is disappointing, it may have created a buying opportunity for inves...

The ASX 200 health stocks index (XHJ) is falling sharply by 2.40% at the time of writing, compared to the broader ASX 200 index which fell by 0.60%. Imaging tech company, Mach7 Tech (ASX:M7T), jumped 6.5% higher this morning after receiving...

The COVID-19 outbreaks in NSW and Victoria have led to a surge in demand for testing, and that trend looks set to show up in the bottom line of pathology network Australian Clinical Labs (ASX:ACL). Australian Clinical Labs, which listed in...

Wall Street mixed as US Fed sends warning on inflation US stock markets finished in mixed territories on Monday, with tech stocks being the main laggards. The Dow Jones rose by 0.21%, but the S&P 500 fell by 0.28% and the tech heavy Nas...

The WAM Capital Limited (ASX: WAM) share price has risen by 6% over the last month. What may be next for the listed investment company (LIC)? What is WAM Capital? For readers that haven’t heard of WAM Capital before, it’s a LIC. The purpos...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

The Australian Clinical Labs Ltd (ASX: ACL) share price has leapt into the green on Thursday as the pathology services company reported its FY21 earnings. Australian Clinical Labs shares are now changing hands at $4.55 apiece, up 8.3% aft...

Top performers from today’s list companies releasing annual results included Swoop (ASX:SWP), Australian Clinical Labs (ASX:ACL) and Fineos (ASX:FCL).   Australian Clinical Labs (ASX:ACL) This company is a pathology stock and like industry...

The ASX 200 health stocks index (XHJ) fell by 1.55% this morning, compared to the broader index which dropped by 0.67%. Topical and and dermatological specialist, Acrux (ASX:ACR), announced that its generic Testosterone Topical Solution USP...

The fund manager Wilson Asset Management (WAM) has told investors about two ASX shares that it has in its portfolio. WAM operates several listed investment companies (LICs). Some focus on larger companies like WAM Leaders Ltd (ASX: WLE). T...

Leading fund manager Wilson Asset Management (WAM) has revealed two ASX shares that it rates as buys within the WAM Research Limited (ASX: WAX) portfolio. WAM operates several listed investment companies (LICs). Two of those LICs are WAM C...

The cavalcade of life science initial public offers (IPOs) and ASX listings shows few signs of receding, with BCAL Diagnostics (ASX:BDX) last week braving the bourse amid choppy global market conditions. In the life sciences IPO Olympiad, w...

An ASX share that only listed a few weeks ago is being ignored by investors, even though next month’s reporting season could light a fire under it. That’s according to Wilson Asset Management portfolio managers Matthew Haupt, Catriona Burn...

The COVID-19 lockdowns of our two biggest cities have prompted brokers to upgrade their earnings calls on several ASX 200 shares. While the protracted lockdowns in Sydney and Melbourne are weighing on the S&P/ASX 200 Index (Index:^AXJO...

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

Point of care diagnostic test provider Lumos Diagnostics (ASX:LDX) is set to list on the ASX on July 5. The company was founded in Melbourne in 2015 and is still headquartered there but has manufacturing facilities in California and Florida...

The first major test for a newly listed ASX stocks is if it can meet or exceed its prospectus forecasts, and Lynch Group (ASX:LGL) passed that test today. Lynch Group has only been listed on the ASX for two months, although its history goes...

The Australian Clinical Labs Ltd (ASX: ACL) share price is pushing higher on Monday. In afternoon trade, the pathology services provider’s shares are up 2% to $3.76. Despite this gain, the Australian Clinical Labs share price is still trad...

The Australian Clinical Labs Ltd (ASX: ACL) share price climbed to a new high of $3.88 during trading today. This follows the pathology service provider’s announcement that it has upgraded its earnings forecast for the 2021 financial year....

Summary The S&P/ASX 200 scaled a new high on Thursday, ending 0.6% up at 7260.1. The index gained as much as 0.9% to hit a fresh intraday high of 7281.8. Australian engineering company Worley was the top gainer, rising 8.13% to AU...

A big surge in energy shares led the ASX into positive territory for the second day in a row. The ASX 200 closed 0.59 per cent higher at 7,260 points although the ASX Emerging Companies Index closed 0.28 per cent lower at 2,188. Energy led...

ShareCafeAPH Helping Humans, and Pets, Through Hemp   One of the more intriguing aspects of the stock market in recent years has been the rehabilitation of cannabis, in the form of the burgeoning medicinal cannabis sector; and Australian P...